Cutler Group’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-207
Closed 7662
2017
Q1
$0 Hold
207
﹤0.01% 7813
2016
Q4
$0 Hold
207
﹤0.01% 7896
2016
Q3
$0 Hold
207
﹤0.01% 7859
2016
Q2
$0 Hold
207
﹤0.01% 7777
2016
Q1
$0 Hold
207
﹤0.01% 7697
2015
Q4
$0 Buy
+207
New +$849 ﹤0.01% 6422

Other funds holding WINT

Cutler Group's WINT Position: Q2 2017 in Review

Cutler Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 207 shares.

Cutler Group first reported a position in WINT in Q4 2015 and held it in 6 quarters. The position peaked at $0 in Q1 2017. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Cutler Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 207 Windtree Therapeutics Inc shares in Q2 2017.
  • Cutler Group first reported a position in Windtree Therapeutics Inc in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Windtree Therapeutics Inc position peaked at $0 in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.